Lumexa Imaging Holdings, Inc. Common Stock Total Liabilities

Latest as of June 2026: $1.19 Billion USD

Lumexa Imaging Holdings, Inc. Common Stock total liabilities. Based on the latest financial reports, Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has total liabilities worth $1.19 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See LMRI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Lumexa Imaging Holdings, Inc. Common Stock (2023–2025)

Total liabilities of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2025. This chart illustrates how Lumexa Imaging Holdings, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See Lumexa Imaging Holdings, Inc. Common Sto (LMRI) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Lumexa Imaging Holdings, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of Lumexa Imaging Holdings, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Hunan Valin Wire & Cable Co Ltd
SHE:001208
China CN¥3.93 Billion
Manchester United Ltd
F:MUF
Germany €1.48 Billion
Highpeak Energy Acquisition Corp
NASDAQ:HPK
USA $1.62 Billion
OCI Co Ltd
KO:010060
Korea ₩3.55 Trillion
Ji'an Mankun Technology Co. Ltd. A
SHE:301132
China CN¥1.16 Billion
Hunan Fazhan Industrial Co Ltd
SHE:000722
China CN¥2.68 Billion
CONMED Corporation
NYSE:CNMD
USA $1.30 Billion
Tinavi Medical Technologies Co Ltd
SHG:688277
China CN¥451.55 Million

Liability Composition Analysis (2023–2025)

This chart breaks down Lumexa Imaging Holdings, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LMRI current and non-current assets.

Liquidity & Leverage Metrics

Lumexa Imaging Holdings, Inc. Common Stock Total Liabilities Ratios Explained

Lumexa Imaging Holdings, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.44 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.94 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.66 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lumexa Imaging Holdings, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lumexa Imaging Holdings, Inc. Common Stock (2023–2025)

The table below shows the annual total liabilities of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2025.

Year Total Liabilities Change
2025-12-31 $1.18 Billion -21.90%
2024-12-31 $1.51 Billion +2.43%
2023-12-31 $1.47 Billion --

About Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI USA Medical Devices
Market Cap
$1.12 Billion
Market Cap Rank
#8294 Global
#2445 in USA
Share Price
$11.67
Change (1 day)
-0.60%
52-Week Range
$6.77 - $18.53
All Time High
$18.53
About

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was foun… Read more